scholarly article | Q13442814 |
P819 | ADS bibcode | 2010PLoSO...512855L |
P356 | DOI | 10.1371/JOURNAL.PONE.0012855 |
P8608 | Fatcat ID | release_yqexioz3r5en5glc2wsqkcc5um |
P932 | PMC publication ID | 2943467 |
P698 | PubMed publication ID | 20877721 |
P5875 | ResearchGate publication ID | 46579814 |
P50 | author | Giuseppe Saglio | Q53342434 |
Brunangelo Falini | Q30119395 | ||
P2093 | author name string | Roberta La Starza | |
Valentina Pierini | |||
Cristina Mecucci | |||
Massimo Fabrizio Martelli | |||
Barbara Crescenzi | |||
Caterina Matteucci | |||
Lucia Brandimarte | |||
Paolo Gorello | |||
Roberto Rosati | |||
Laura Berchicci | |||
Enrico Gottardi | |||
Francesco Arcioni | |||
Antonella Santucci | |||
Constantina Sambani | |||
Anna Aventin | |||
Valeria Nofrini | |||
P2860 | cites work | 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. | Q37549908 |
Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia | Q47207273 | ||
TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. | Q50629545 | ||
Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. | Q54627394 | ||
Submicroscopic deletions in 5q- associated malignancies | Q57135685 | ||
Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome | Q63248769 | ||
Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ? | Q80491212 | ||
Molecular characterization of acute myeloid leukemia | Q81555522 | ||
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype | Q27824827 | ||
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). | Q27824861 | ||
DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer | Q28253026 | ||
Role of nucleophosmin in embryonic development and tumorigenesis | Q28591282 | ||
Nucleophosmin is required for DNA integrity and p19Arf protein stability | Q28593126 | ||
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. | Q31012437 | ||
Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis | Q33412120 | ||
A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome | Q33579912 | ||
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia | Q33797115 | ||
Distinct haematological disorder with deletion of long arm of no. 5 chromosome | Q34209827 | ||
Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response. | Q34549318 | ||
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype | Q35011883 | ||
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. | Q35561038 | ||
Cellular UV damage responses--functions of tumor suppressor p53. | Q36142296 | ||
Nucleophosmin and cancer | Q36516405 | ||
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia | Q36600942 | ||
Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer | Q37423777 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
P304 | page(s) | e12855 | |
P577 | publication date | 2010-09-21 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | NPM1 deletion is associated with gross chromosomal rearrangements in leukemia | |
P478 | volume | 5 |
Q91106400 | Acute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q) |
Q87226130 | Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome |
Q43160323 | Different boundaries characterize isolated and non-isolated 5q deletions in myelodysplastic syndromes and acute myeloid leukemias |
Q42672788 | Effect of nucleophosmin1 haploinsufficiency on hematopoietic stem cells |
Q37718403 | NPM1 Gene Type A Mutation in Bulgarian Adults with Acute Myeloid Leukemia: A Single-Institution Study |
Q42724172 | NPM1 gene deletions in myelodysplastic syndromes with 5q- and complex karyotype |
Q38527837 | Recent Advances in the 5q- Syndrome |
Q35925259 | Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited |
Q37923939 | Update on cytogenetic and molecular changes in myelodysplastic syndromes |
Search more.